ERβ-selective compounds are a very attractive alternative to non-selective estrogens currently in MHT because of the anti-proliferative and anti-tumor properties of ERβ [21]–[24], and the finding that MF101 produced a significant reduction in hot flashes and night sweats [25]. This evidence concerns the gene ESR2 and neoplasm.